Magnetic resonance imaging first-pass myocardial perfusion in evaluation of hemodynamic effects of myocardial bridging.
Myocardial bridging is a congenital variation that may lead to angina, myocardial ischemia, and even sudden death. We report the use of magnetic resonance imaging first-pass myocardial perfusion in evaluation of hemodynamic effects of myocardial bridging in a symptomatic case.
Canyigit
Murat
M
Department of Radiology, Hacettepe University, Faculty of Medicine, Sihhiye, Ankara, Turkey.
Turkbey
Baris
B
Hazirolan
Tuncay
T
Peynircioglu
Bora
B
Aytemir
Kudret
K
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D001285:Atropine / Q000008:administration & dosage; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage; D002637:Chest Pain / Q000209:etiology; D003287:Contrast Media / Q000008:administration & dosage; D003326:Coronary Circulation; D004280:Dobutamine / Q000008:administration & dosage; D005080:Exercise Test / Q000379:methods; D005500:Follow-Up Studies; D019786:Gadolinium DTPA; D006321:Heart / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D054084:Myocardial Bridging / Q000175:diagnosis* / Q000503:physiopathology; D009206:Myocardium / Q000473:pathology*; D010092:Oximetry
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D003287:Contrast Media; D004280:Dobutamine; D001285:Atropine; D019786:Gadolinium DTPA